• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型含 1,2,3-三唑片段的取代苯甲酰胺衍生物的设计、合成及作为强效人二氢乳清酸脱氢酶抑制剂的生物评价。

Design, synthesis, and biological evaluation of novel substituted benzamide derivatives bearing a 1,2,3-triazole moiety as potent human dihydroorotate dehydrogenase inhibitors.

机构信息

Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenyang 110016, PR China.

Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, 103 Wenhua Road, Shenyang 110016, PR China.

出版信息

Bioorg Chem. 2018 Feb;76:528-537. doi: 10.1016/j.bioorg.2017.12.025. Epub 2017 Dec 30.

DOI:10.1016/j.bioorg.2017.12.025
PMID:29316525
Abstract

A novel series of substituted benzamide derivatives bearing a 1,2,3-triazole moiety were designed and synthesized by click chemistry. Human dihydroorotate dehydrogenase inhibition assay was used to evaluate the synthesized compounds as potent hDHODH inhibitors. Most compounds showed moderate to significant potency, accompanied with a suitable clogD value and compounds 4d, 4o, and 5j effectively inhibited the activity of hDHODH with IC values of 2.1, 2.1 and 1.5 μM, respectively. Compound 4o also effectively suppressed proliferation of the activated PBMCs. The study of structure-activity relationships also revealed that a suitable substitution on para-position of terminal phenyl ring was crucial for high activity. Together, the most promising compound 4o might serve as a novel hDHODH inhibitors for further investigation.

摘要

通过点击化学,设计并合成了一系列新型取代苯甲酰胺衍生物,其中含有 1,2,3-三唑部分。采用人二氢乳清酸脱氢酶抑制试验评估合成化合物作为潜在的 hDHODH 抑制剂的活性。大多数化合物表现出中等至显著的活性,同时具有合适的 clogD 值,化合物 4d、4o 和 5j 分别以 2.1、2.1 和 1.5μM 的 IC 值有效抑制 hDHODH 的活性。化合物 4o 还能有效抑制活化的 PBMCs 的增殖。构效关系研究还表明,末端苯环对位的适当取代对于高活性至关重要。总的来说,最有前途的化合物 4o 可能作为一种新型 hDHODH 抑制剂,值得进一步研究。

相似文献

1
Design, synthesis, and biological evaluation of novel substituted benzamide derivatives bearing a 1,2,3-triazole moiety as potent human dihydroorotate dehydrogenase inhibitors.新型含 1,2,3-三唑片段的取代苯甲酰胺衍生物的设计、合成及作为强效人二氢乳清酸脱氢酶抑制剂的生物评价。
Bioorg Chem. 2018 Feb;76:528-537. doi: 10.1016/j.bioorg.2017.12.025. Epub 2017 Dec 30.
2
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds.基于羟基化唑类支架的高效人二氢乳清酸脱氢酶抑制剂的设计、合成、生物学评价及X射线结构研究
Eur J Med Chem. 2017 Mar 31;129:287-302. doi: 10.1016/j.ejmech.2017.02.017. Epub 2017 Feb 14.
3
Discovery of a novel series of hDHODH inhibitors with anti-pulmonary fibrotic activities.发现具有抗肺纤维化活性的新型 hDHODH 抑制剂系列。
Bioorg Chem. 2019 May;86:44-51. doi: 10.1016/j.bioorg.2019.01.011. Epub 2019 Jan 7.
4
Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.新型取代喹啉-2-甲酰胺衍生物作为人二氢乳清酸脱氢酶(hDHODH)抑制剂和抗癌剂的设计、合成及药理评价
Eur J Med Chem. 2014 Jul 23;82:385-93. doi: 10.1016/j.ejmech.2014.05.064. Epub 2014 May 27.
5
[Design, synthesis and structure-activity relationship studies of human dihydroorotate dehydrogenase inhibitors].[人二氢乳清酸脱氢酶抑制剂的设计、合成及构效关系研究]
Yao Xue Xue Bao. 2017 Feb;52(2):264-70.
6
Bifunctional Naphtho[2,3-][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production.双功能萘并[2,3-][1,2,3]三唑-4,9-二酮化合物通过抑制二氢乳清酸脱氢酶和诱导活性氧物种产生来发挥其在体外和体内的抗肿瘤作用。
J Med Chem. 2020 Jul 23;63(14):7633-7652. doi: 10.1021/acs.jmedchem.0c00512. Epub 2020 Jul 1.
7
Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment.新型噻吩并嘧啶酮类培哚普利衍生物的设计、合成及作为强效人二氢乳清酸脱氢酶抑制剂在恶性肿瘤治疗中的生物评价。
J Med Chem. 2021 Dec 23;64(24):18175-18192. doi: 10.1021/acs.jmedchem.1c01711. Epub 2021 Dec 14.
8
Synthesis of 2-,4,-6-, and/or 7-substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents: 3D QSAR-assisted design.合成 2-、4-、6- 和/或 7-取代喹啉衍生物作为人二氢乳清酸脱氢酶 (hDHODH) 抑制剂和抗癌剂:3D QSAR 辅助设计。
Bioorg Med Chem Lett. 2019 Apr 1;29(7):917-922. doi: 10.1016/j.bmcl.2019.01.038. Epub 2019 Jan 31.
9
Structural Optimization and Structure-Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase.4-噻唑烷酮衍生物作为新型人二氢乳清酸脱氢酶抑制剂的结构优化及构效关系研究。
Molecules. 2019 Jul 31;24(15):2780. doi: 10.3390/molecules24152780.
10
A novel series of teriflunomide derivatives as orally active inhibitors of human dihydroorotate dehydrogenase for the treatment of colorectal carcinoma.一种新型的噻吩并嘧啶衍生物系列,作为人二氢乳清酸脱氢酶的口服活性抑制剂,用于治疗结直肠癌。
Eur J Med Chem. 2022 Aug 5;238:114489. doi: 10.1016/j.ejmech.2022.114489. Epub 2022 May 26.

引用本文的文献

1
Fluorinated triazoles as privileged potential candidates in drug development-focusing on their biological and pharmaceutical properties.氟化三唑作为药物开发中具有优势的潜在候选物——聚焦于其生物学和药学性质
Front Chem. 2022 Aug 9;10:926723. doi: 10.3389/fchem.2022.926723. eCollection 2022.
2
1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview.含 1,2,3-三唑的杂合体作为药物化学中的先导化合物:最新概述。
Bioorg Med Chem. 2019 Aug 15;27(16):3511-3531. doi: 10.1016/j.bmc.2019.07.005. Epub 2019 Jul 4.